Skip to Main Content

Advertisement

Skip Nav Destination

Abstract 5620: Therapeutic targeting of glypican-3 using TGF-β2 as a novel treatment approach for HCC

Cancer Res (2012) 72 (8_Supplement): 5620.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal